SPATA2 Activators are a class of chemical compounds that have garnered significant attention in the realm of molecular biology and cellular signaling pathways. These molecules are known for their ability to interact with and modulate the function of SPATA2, a protein that plays a crucial role in various cellular processes. SPATA2, short for Spermatogenesis-Associated 2, is a protein encoded by the SPATA2 gene and is part of a complex involved in the regulation of innate immunity and autophagy.
SPATA2 Activators exert their effects by binding to SPATA2 and influencing its interactions with other proteins within the cell. SPATA2 is an essential component of the linear ubiquitin assembly complex (LUBAC), which is responsible for attaching linear ubiquitin chains to various cellular proteins. This post-translational modification plays a pivotal role in regulating immune responses, inflammation, and cell survival. SPATA2 Activators have been identified as molecules that can enhance or modulate the activity of SPATA2 within the LUBAC complex, thereby impacting the downstream signaling pathways associated with it.SPATA2 Activators can have diverse effects on cellular processes. By influencing the function of SPATA2, these chemical compounds have the potential to fine-tune immune responses, regulate cellular stress responses, and impact cell fate decisions. Furthermore, they can serve as valuable tools for researchers studying the intricate mechanisms of autophagy and innate immunity. While their specific applications and implications may vary depending on the context of their use, SPATA2 Activators represent a promising avenue of study in the field of molecular biology and cellular signaling, offering insights into the fundamental processes that govern cellular behavior.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
A calcineurin inhibitor that can increase the activity of NFAT (nuclear factor of activated T-cells) by preventing its dephosphorylation, which may indirectly lead to the activation of SPATA2 through NFAT-mediated signaling pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
A diacylglycerol (DAG) analog that robustly activates protein kinase C (PKC), potentially enhancing SPATA2 function by influencing downstream signaling pathways that SPATA2 is involved in. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
An adenylyl cyclase activator that increases cyclic AMP (cAMP) levels, potentially leading to the activation of PKA (protein kinase A). PKA can phosphorylate various proteins that may interact with or modify the activity of SPATA2. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
A calcium ionophore that raises intracellular calcium levels, which could activate calcium-dependent protein kinases that influence SPATA2 activity. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
An inhibitor of ADP-ribosylation factor (ARF), which leads to the disassembly of the Golgi apparatus and could affect SPATA2 activity by modulating intracellular trafficking pathways. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
A sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA) pump inhibitor, leading to increased cytosolic calcium levels, which could indirectly activate SPATA2 through calcium-dependent signaling pathways. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
A protein phosphatase inhibitor, which could enhance SPATA2 activity by preventing dephosphorylation of proteins within signaling pathways that SPATA2 is part of. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
An inhibitor of protein synthesis that activates stress-activated protein kinases (SAPKs), potentially influencing SPATA2 activity by altering cellular stress responses. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Another protein phosphatase inhibitor that could indirectly enhance SPATA2 activity by modulating the phosphorylation state of proteins in pathways that SPATA2 is involved in. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that may lead to the activation of SPATA2 by affecting the PI3K/Akt signaling pathway, which is involved in various cellular processes that could interact with SPATA2 function. | ||||||